McBarron Paul 4
4 · Cyclacel Pharmaceuticals, Inc. · Filed Dec 9, 2019
Insider Transaction Report
Form 4
McBarron Paul
DirectorEVP, Finance, CFO, COO
Transactions
- Award
Option
2019-12-05+13,022→ 13,022 totalExercise: $1.74Exp: 2027-12-29→ Common Stock (13,022 underlying) - Award
Option
2019-12-05+11,980→ 11,980 totalExercise: $1.56Exp: 2028-02-22→ Common Stock (11,980 underlying)
Footnotes (2)
- [F1]On December 29, 2017, Paul McBarron was granted an option to purchase certain shares of common stock, which option shall vest according to the satisfaction of performance criteria. Certain performance criteria were confirmed to have been met on December 5, 2019, resulting in the vesting of the option as to 13,022 shares.
- [F2]On February 22, 2018, Paul McBarron was granted an option to purchase certain shares of common stock, which option shall vest according to the satisfaction of performance criteria. Certain performance criteria were confirmed to have been met on December 5, 2019, resulting in the vesting of the option as to 11,980 shares.